Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 3.1 Exhibit 3.1(A)
- 3.24 Exhibit 3.24(A)
- 3.24 Exhibit 3.24(B)
- 3.25 Exhibit 3.25(A)
- 3.25 Exhibit 3.25(B)
- 3.26 Exhibit 3.26(A)
- 3.26 Exhibit 3.26(B)
- 3.27 Exhibit 3.27(A)
- 3.27 Exhibit 3.27(B)
- 3.28 Exhibit 3.28(A)
- 3.28 Exhibit 3.28(B)
- 3.29 Exhibit 3.29(A)
- 3.29 Exhibit 3.29(B)
- 3.30 Exhibit 3.30(A)
- 3.30 Exhibit 3.30(B)
- 3.31 Exhibit 3.31(A)
- 3.31 Exhibit 3.31(B)
- 3.32 Exhibit 3.32(A)
- 3.32 Exhibit 3.32(B)
- 3.33 Exhibit 3.33(A)
- 3.33 Exhibit 3.33(B)
- 3.34 Exhibit 3.34(A)
- 3.34 Exhibit 3.34(B)
- 3.35 Exhibit 3.35(A)
- 3.35 Exhibit 3.35(B)
- 3.36 Exhibit 3.36(A)
- 3.36 Exhibit 3.36(B)
- 3.37 Exhibit 3.37(A)
- 3.37 Exhibit 3.37(B)
- 4.3 Exhibit 4.3
- 4.4 Exhibit 4.4
- 4.6 Exhibit 4.6
- 4.7 Exhibit 4.7
- 4.9 Exhibit 4.9
- 4.10 Exhibit 4.10
- 4.11 Exhibit 4.11
- 5.1 Exhibit 5.1
- 5.2 Exhibit 5.2
- 5.3 Exhibit 5.3
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 12.1 Exhibit 12.1
- 23.2 Exhibit 23.2
- 25.1 EX-25.1
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
Aor Management Co Of Missouri similar filings
- 15 Oct 09 Registration of securities issued in business combination transactions
- 16 Mar 05 Registration of securities issued in business combination transactions (amended)
- 14 Mar 05 Registration of securities issued in business combination transactions (amended)
- 17 Dec 04 Registration of securities issued in business combination transactions
- 16 Apr 02 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-4 of US Oncology, Inc. of our report dated February 26, 2004 relating to the financial statements and financial statement schedules of US Oncology, Inc., which appears in such Registration Statement. We also consent to the references to us under the headings “Experts” and “Selected Financial Data” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Houston, Texas
December 17, 2004